Taylor-Robinson SD - Search Results

1

Modulation of neural activation following treatment of hepatic encephalopathy.

McPhail MJ, Leech R, Grover VP, Fitzpatrick JA, Dhanjal NS, Crossey MM, Pflugrad H, Saxby BK, Wesnes K, Dresner MA, Waldman AD, Thomas HC, Taylor-Robinson SD. McPhail MJ, et al. Neurology. 2013 Mar 12;80(11):1041-7. doi: 10.1212/WNL.0b013e31828726e1. Epub 2013 Feb 20. Neurology. 2013. PMID: 23427320 Free PMC article.

2

Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy.

Taylor-Robinson SD, Sargentoni J, Marcus CD, Morgan MY, Bryant DJ. Taylor-Robinson SD, et al. Metab Brain Dis. 1994 Dec;9(4):347-59. doi: 10.1007/BF02098881. Metab Brain Dis. 1994. PMID: 7898401

3

Diagnosis and treatment of chronic hepatic encephalopathy.

Seery JP, Aspinall RJ, Taylor-Robinson SD. Seery JP, et al. Hosp Med. 1998 Mar;59(3):200-4. Hosp Med. 1998. PMID: 9722346 Review.

4

Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study.

Hu MT, Taylor-Robinson SD, Chaudhuri KR, Bell JD, Morris RG, Clough C, Brooks DJ, Turjanski N. Hu MT, et al. J Neurol Neurosurg Psychiatry. 1999 Jul;67(1):20-6. doi: 10.1136/jnnp.67.1.20. J Neurol Neurosurg Psychiatry. 1999. PMID: 10369817 Free PMC article.

5

MRI guidance of infra-red laser liver tumour ablations, utilising an open MRI configuration system: technique and early progress.

de Jode MG, Lamb GM, Thomas HC, Taylor-Robinson SD, Gedroyc WM. de Jode MG, et al. J Hepatol. 1999 Aug;31(2):347-53. doi: 10.1016/s0168-8278(99)80234-7. J Hepatol. 1999. PMID: 10453950 Clinical Trial.

6

Cerebral proton and phosphorus-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy.

Taylor-Robinson SD, Buckley C, Changani KK, Hodgson HJ, Bell JD. Taylor-Robinson SD, et al. Liver. 1999 Oct;19(5):389-98. doi: 10.1111/j.1478-3231.1999.tb00067.x. Liver. 1999. PMID: 10533796

7

Possible mechanisms of action and reasons for failure of antiviral therapy in chronic hepatitis C.

Thomas HC, Török ME, Forton DM, Taylor-Robinson SD. Thomas HC, et al. J Hepatol. 1999;31 Suppl 1:152-9. doi: 10.1016/s0168-8278(99)80393-6. J Hepatol. 1999. PMID: 10622579 Review.

8

Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study.

Hu MT, Taylor-Robinson SD, Chaudhuri KR, Bell JD, Labbé C, Cunningham VJ, Koepp MJ, Hammers A, Morris RG, Turjanski N, Brooks DJ. Hu MT, et al. Brain. 2000 Feb;123 ( Pt 2):340-52. doi: 10.1093/brain/123.2.340. Brain. 2000. PMID: 10648441

9

Increased availability of central benzodiazepine receptors in patients with chronic hepatic encephalopathy and alcohol related cirrhosis.

Jalan R, Turjanski N, Taylor-Robinson SD, Koepp MJ, Richardson MP, Wilson JA, Bell JD, Brooks DJ. Jalan R, et al. Gut. 2000 Apr;46(4):546-52. doi: 10.1136/gut.46.4.546. Gut. 2000. PMID: 10716686 Free PMC article.

10

Intracellular pH measurements of the whole head and the basal ganglia in chronic liver disease: a phosphorus-31 MR spectroscopy study.

Patel N, Forton DM, Coutts GA, Thomas HC, Taylor-Robinson SD. Patel N, et al. Metab Brain Dis. 2000 Sep;15(3):223-40. doi: 10.1007/BF02674531. Metab Brain Dis. 2000. PMID: 11206591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters